[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acute-coronary-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":116,"states":117},"Acute Coronary Syndrome",17,14,[8,16,22,28,35,41,47,53,59,66,72,78,84,90,96,103,110],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07032389","A Polypill for Acute Coronary Syndrome",[12],"Phase 2","RECRUITING","2026-08-26T02:18:23.582895Z","2026-05-05T02:43:29.194821Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07541014","TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome",[],"2026-08-26T02:16:26.411851Z","2026-05-05T02:43:28.674878Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05412862","Positive Emotions Following Acute Cardiac Events",[],"2026-08-26T02:17:29.353236Z","2026-05-05T02:43:28.219151Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT05918861","Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS",[32],"Phase 3","2026-08-26T02:19:00.742020Z","2026-05-05T02:43:28.016149Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05738408","Remote Smoking Cessation in Hospitalized Cardiac Patients",[],"2026-08-26T02:15:29.632183Z","2026-05-05T02:35:31.867867Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT05897632","CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)",[],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:27.290002Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06927739","Focused Orticumab Research for Treating Inflammation in Coronary Arteries",[12],"2026-08-26T02:15:10.362237Z","2026-05-05T02:35:31.651909Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT05733767","Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study",[12],"2026-08-26T02:18:29.369233Z","2026-05-05T02:35:31.774833Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT04982419","Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial",[63],"Phase 2\u002FPhase 3","2026-08-26T02:18:31.164304Z","2026-05-05T02:43:27.931296Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06481943","A Prospective Research Investigation of Ischemia Using MCG",[],"2026-08-26T02:18:04.640417Z","2026-05-13T02:55:06.494468Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05426083","Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock",[],"2026-08-03T03:46:02.954252Z","2026-05-13T02:55:06.348183Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05412927","AngelMed Guardian® System PMA Post Approval Study",[],"2026-08-26T02:17:47.813245Z","2026-05-13T02:55:06.347920Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT07258290","Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions",[],"2026-08-26T02:15:59.318403Z","2026-06-17T19:21:16.686466Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06996639","Breaking Fasts Ahead of Cardiac Caths",[],"2026-08-26T02:16:28.221034Z","2026-05-29T15:36:40.178757Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT07676097","Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study",[],"NOT_YET_RECRUITING","2026-08-26T02:18:20.384845Z","2026-07-05T03:45:20.439235Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT06374498","Study to Determine the Clinical Significance of Intravascular OCT-NIRAF",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:05.997056Z","2026-06-16T05:54:07.749845Z",{"nct_id":111,"title":112,"phases":113,"status":107,"updated_at":114,"content_modified":115},"NCT04599192","Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women",[],"2026-08-26T02:16:23.080181Z","2026-07-05T18:42:10.697195Z",[],[118,122,125,128,131,134,137,141],{"state":119,"count":120,"slug":121},"California",4,"california",{"state":123,"count":120,"slug":124},"Florida","florida",{"state":126,"count":120,"slug":127},"Michigan","michigan",{"state":129,"count":120,"slug":130},"Minnesota","minnesota",{"state":132,"count":120,"slug":133},"New York","new-york",{"state":135,"count":120,"slug":136},"Texas","texas",{"state":138,"count":139,"slug":140},"District of Columbia",3,"district-of-columbia",{"state":142,"count":139,"slug":143},"Massachusetts","massachusetts"]